HIMS

MX:HIMS Mexico Drug Manufacturers - Specialty & Generic
Market Cap
$4.71 Billion
MX$97.05 Billion MXN
Market Cap Rank
#3011 Global
#11 in Mexico
Share Price
MX$442.00
Change (1 day)
+0.02%
52-Week Range
MX$252.00 - MX$1249.31
All Time High
MX$1249.31
About

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase… Read more

HIMS (HIMS) - Total Assets

Latest total assets as of December 2025: MX$2.15 Billion MXN

Based on the latest financial reports, HIMS (HIMS) holds total assets worth MX$2.15 Billion MXN as of December 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

HIMS - Total Assets Trend (2021–2025)

This chart illustrates how HIMS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

HIMS - Asset Composition Analysis

Current Asset Composition (December 2025)

HIMS's total assets of MX$2.15 Billion consist of 35.6% current assets and 64.4% non-current assets.

Asset Category Amount (MXN) % of Total Assets
Cash & Equivalents MX$0.00 10.6%
Accounts Receivable MX$32.15 Million 1.5%
Inventory MX$80.13 Million 3.7%
Property, Plant & Equipment MX$0.00 0.0%
Intangible Assets MX$196.12 Million 9.1%
Goodwill MX$278.32 Million 12.9%

Asset Composition Trend (2021–2025)

This chart illustrates how HIMS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: HIMS's current assets represent 35.6% of total assets in 2025, a decrease from 64.2% in 2021.
  • Cash Position: Cash and equivalents constituted 10.6% of total assets in 2025, down from 17.1% in 2021.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, a decrease from 32.0% in 2021.
  • Asset Diversification: The largest asset category is goodwill at 12.9% of total assets.

HIMS Competitors by Total Assets

Key competitors of HIMS based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

HIMS - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.65 - 2.09

Strong asset utilization - HIMS generates 1.09x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -25.60% - 17.81%

Solid ROA - For every $100 in assets, HIMS generates $5.96 in net profit.

HIMS - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.90 1.79 2.80
Quick Ratio 1.70 1.50 2.48
Cash Ratio 0.00 0.00 0.00
Working Capital MX$363.21 Million MX$ 174.46 Million MX$ 168.41 Million

HIMS - Advanced Valuation Insights

This section examines the relationship between HIMS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 9.90
Latest Market Cap to Assets Ratio 2.07
Asset Growth Rate (YoY) 204.5%
Total Assets MX$2.15 Billion
Market Capitalization $4.46 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values HIMS's assets at a significant premium ( 2.07x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: HIMS's assets grew by 204.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for HIMS (2021–2025)

The table below shows the annual total assets of HIMS from 2021 to 2025.

Year Total Assets Change
2025-12-31 MX$2.15 Billion +204.54%
2024-12-31 MX$707.54 Million +60.37%
2023-12-31 MX$441.19 Million +20.43%
2022-12-31 MX$366.34 Million -12.90%
2021-12-31 MX$420.58 Million --